IL13responsive

IL13responsive is a term used to describe cells, tissues, or biological processes that respond to the cytokine interleukin-13 (IL-13). IL-13 is a signaling molecule primarily produced by T-helper type 2 (Th2) cells, mast cells, eosinophils, and basophils. It plays a crucial role in the regulation of immune responses, particularly in allergic reactions and parasitic infections.

Cells considered IL13responsive typically express the IL-13 receptor complex, which includes the IL-13 receptor alpha 1 (IL13Rα1) and the shared IL-4 receptor alpha (IL4Rα) chains. Binding of IL-13 to this receptor activates intracellular signaling pathways, especially the JAK-STAT pathway, leading to changes in gene expression that influence cell behavior. These responses include promoting mucus production, eosinophil recruitment, and fibroblast activation, often associated with allergic inflammation and airway remodeling.

IL13responsive mechanisms are significant in the pathophysiology of diseases such as asthma, atopic dermatitis, and certain forms of chronic rhinosinusitis. Therapeutic strategies targeting IL-13 or its receptor pathways aim to mitigate these allergic and inflammatory responses. Biologic agents, such as monoclonal antibodies directed against IL-13 (e.g., Lebrikizumab, Tralokinumab), have been developed and approved for the treatment of severe allergic diseases.

Understanding IL13responsive pathways contributes to the broader field of immunology and helps in designing targeted therapies for inflammatory and allergic conditions. Ongoing research continues to elucidate the diverse roles of IL-13 and the mechanisms underlying cellular responsiveness, potentially expanding therapeutic options in the future.